Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hawaii Cellular Therapy and Transplant Center (HCTTC) is a specialized medical facility located at The Queen's Medical Center in Honolulu, Hawaii. It is the only program in the state of Hawaii accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) for both autologous and allogeneic stem cell transplantation. The center provides comprehensive care for patients with life-threatening blood cancers and disorders, including leukemia, lymphoma, and multiple myeloma. In addition to traditional bone marrow transplants, HCTTC offers advanced cellular immunotherapies such as CAR-T cell therapy. The facility serves as a vital resource for the Pacific region, allowing local patients to access complex, high-acuity treatments without the need for mainland travel.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hawaii Cellular Therapy.